Vanguard Asset Management
PRCT icon

Vanguard Asset Management’s Procept Biorobotics PRCT Stock Holding History

Vanguard Asset Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Hold
47,152
– – ﹤0.01% 1847
2026
Q1 		$1.18M Buy
+47,152
New +$1.33M ﹤0.01% 1713

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Asset Management's PRCT Position: Q2 2026 in Review

Vanguard Asset Management held its Procept Biorobotics (PRCT) position steady in Q2 2026 at 47,152 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1847.

Vanguard Asset Management first reported a position in PRCT in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.18M in Q1 2026. 238 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Vanguard Asset Management held 47,152 shares of Procept Biorobotics worth $1.06M as of Q2 2026.
  • Vanguard Asset Management left its Procept Biorobotics share count unchanged in Q2 2026.
  • Procept Biorobotics made up ﹤0.01% of Vanguard Asset Management's portfolio in Q2 2026, its #1847 holding.
  • Vanguard Asset Management first reported a position in Procept Biorobotics in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Asset Management's Procept Biorobotics position peaked at $1.18M in Q1 2026.
  • 238 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.